NCT00975221 Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy Status COMPLETED Phase PHASE3
NCT00975000 Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00967538 Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments Status COMPLETED Phase PHASE4
NCT00965666 Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia Status COMPLETED Phase EARLY_PHASE1
NCT00958386 Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA) Status COMPLETED Phase PHASE2
NCT00953446 Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma Status TERMINATED Phase NA
NCT00950989 Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate Status COMPLETED Phase PHASE2
NCT00950950 A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass Status COMPLETED Phase PHASE1
NCT00950911 Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only Status COMPLETED Phase PHASE3
NCT00947544 Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders Status COMPLETED Phase PHASE2
NCT00947297 Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) Status COMPLETED Phase PHASE3
NCT00943943 Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations Status COMPLETED Phase PHASE1
NCT00941863 Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006) Status COMPLETED Phase PHASE1
NCT00940316 Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00936988 A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism Status COMPLETED Phase PHASE2
NCT00936897 A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates Status COMPLETED Phase PHASE3
NCT00936650 A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) Status COMPLETED Phase PHASE2